Distributor inventory | Tablet

Treatment of susceptible bacterial infections such as acute bacterial sinusitis, acute otitis media, community-acquired pneumonia/bronchitis exacerbations, urinary tract infections, and skin & soft tissue infections.

Cefpodoxime is a third-generation cephalosporin antibiotic that inhibits bacterial cell wall synthesis leading to bacterial death. Clavulanic acid is a beta-lactamase inhibitor that protects cefpodoxime from degradation by beta-lactamase–producing bacteria, improving coverage against resistant strains.

Oral tablet. Take exactly as prescribed by the doctor, usually with food to reduce stomach upset and improve absorption. Swallow whole with water; do not stop early even if you feel better; complete the full course.

Diarrhoea, nausea, vomiting, abdominal pain, indigestion, headache, dizziness, rash, itching, vaginal yeast infection, taste disturbance

Use only for bacterial infections. Risk of allergy/hypersensitivity in patients with penicillin/cephalosporin allergy—seek help for rash, swelling, breathing difficulty. May cause diarrhoea; if severe/watery/bloody, consider C. difficile and consult doctor. Use with caution in kidney disease (dose adjustment may be needed) and in history of colitis. Prolonged use may cause superinfection. Can affect some lab tests (e.g., Coombs test).

Probenecid (may increase antibiotic levels), anticoagulants such as warfarin (may increase bleeding risk/INR), antacids/H2 blockers/PPIs (may reduce cefpodoxime absorption), live bacterial vaccines (e.g., oral typhoid) may have reduced effect, other nephrotoxic drugs (monitor in renal impairment)

Store below 25°C in a dry place, protected from light and moisture. Keep in original blister pack and out of reach of children.

Cefpodoxime 200 mg + Clavulanic acid 125 mg tablets (e.g., Cepodem CV 200, Podox CV 200, Cefodox CV 200, Cepod CV 200, Taxim-O CV 200)